|
PRELID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.48079998158113E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60759999984417E-07 |
| Normal-vs-Stage2 |
1.056820E-01 |
| Normal-vs-Stage3 |
1.081620E-02 |
| Normal-vs-Stage4 |
3.048000E-02 |
| Stage1-vs-Stage2 |
5.814400E-01 |
| Stage1-vs-Stage3 |
7.549200E-01 |
| Stage1-vs-Stage4 |
5.877800E-01 |
| Stage2-vs-Stage3 |
8.048400E-01 |
| Stage2-vs-Stage4 |
4.263800E-01 |
| Stage3-vs-Stage4 |
4.617400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.76940004262372E-09 |
| Normal-vs-AfricanAmerican |
1.056450E-03 |
| Normal-vs-Asian |
4.236300E-02 |
| Caucasian-vs-AfricanAmerican |
1.699190E-01 |
| Caucasian-vs-Asian |
3.661700E-02 |
| AfricanAmerican-vs-Asian |
4.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.79530000035777E-07 |
| Normal-vs-Female |
1.05299999830777E-08 |
| Male-vs-Female |
1.860580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.278300E-03 |
| Normal-vs-Extreme_Weight |
2.01389999999746E-05 |
| Normal-vs-Obese |
3.228300E-04 |
| Normal-vs-Extreme_Obese |
2.852200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.024600E-01 |
| Normal_Weight-vs-Obese |
6.074400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.117000E-01 |
| Extreme_Weight-vs-Obese |
9.534800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.996000E-01 |
| Obese-vs-Extreme_Obese |
4.296600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.66839999996105E-06 |
| Normal-vs-Age(41-60Yrs) |
7.43739999586879E-08 |
| Normal-vs-Age(61-80Yrs) |
2.32919999999526E-05 |
| Normal-vs-Age(81-100Yrs) |
1.453420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.123400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.299570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.609600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.594400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.328000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.336400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.10020000279698E-08 |
| Normal-VS-Type2 PRCC |
2.616000E-03 |
| Normal-VS-KIRP CIMP |
6.813200E-04 |
| Normal-VS-Unclassified PRCC |
2.081000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.573000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.638200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.944400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.443000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.653800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.020800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.901300E-03 |
| Normal-vs-N1 |
7.155300E-04 |
| Normal-vs-N2 |
2.306600E-01 |
| N0-vs-N1 |
7.837400E-01 |
| N0-vs-N2 |
8.829600E-01 |
| N1-vs-N2 |
9.096800E-01 |
|
|
